SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-11-001446
Filing Date
2011-01-10
Accepted
2011-01-10 11:49:58
Documents
3
Period of Report
2011-01-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v207699_8-k.htm 8-K 37696
2 v207699_ex10-1.htm EX-10.1 58498
3 v207699_ex99-1.htm EX-99.1 15257
  Complete submission text file 0001144204-11-001446.txt   113280
Mailing Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019
Business Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019 (212) 582-3950
MANHATTAN PHARMACEUTICALS INC (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32639 | Film No.: 11519287
SIC: 2834 Pharmaceutical Preparations